The medication occupies GLP-1 receptors to work in the following ways: Semaglutide acts on the hunger control center (lateral hypothalamus) of the brain to promote a feeling of fullness, which suppresses an urge to eat and reduces the intensity of hunger cravings
In tests on animal models, wounds showed faster contraction, better epithelialisation, more granulation tissue, and higher antioxidant enzyme activity [5,6]
10.3389/fnins.2021.646678 77
TRZ is given by subcutaneous route only once per week, has a long half-life, and crosses BBB, leading to the induction of a satiety center in the hypothalamus (Boer et al
doi: 10.1016/J.IJBIOMAC.2023.126049 154 SamS.JosephB.ThomasS
Gadalla KK, Bailey ME, Spike RC, Ross PD, Woodard KT, Kalburgi SN, et al